Abstract:Although aerobic glycolysis (the Warburg effect) is a hallmark of cancer, key questions, including when, how, and why cancer cells become highly glycolytic, remain less clear. For a largely unknown regulatory mechanism, a rate-limiting glycolytic enzyme pyruvate kinase M2 (PKM2) isoform is exclusively expressed in embryonic, proliferating, and tumor cells, and plays an essential role in tumor metabolism and growth. Because the receptor tyrosine kinase/PI3K/AKT/mammalian target of rapamycin (RTK/PI3K/AKT/mTOR) signaling cascade is a frequently altered pathway in cancer, we explored its potential role in cancer metabolism. We identified mTOR as a central activator of the Warburg effect by inducing PKM2 and other glycolytic enzymes under normoxic conditions. PKM2 level was augmented in mouse kidney tumors due to deficiency of tuberous sclerosis complex 2 and consequent mTOR activation, and was reduced in human cancer cells by mTOR suppression. mTOR up-regulation of PKM2 expression was through hypoxia-inducible factor 1α (HIF1α)-mediated transcription activation, and c-Myc–heterogeneous nuclear ribonucleoproteins (hnRNPs)-dependent regulation of PKM2 gene splicing. Disruption of PKM2 suppressed oncogenic mTOR-mediated tumorigenesis. Unlike normal cells, mTOR hyperactive cells were more sensitive to inhibition of mTOR or glycolysis. Dual suppression of mTOR and glycolysis synergistically blunted the proliferation and tumor development of mTOR hyperactive cells. Even though aerobic glycolysis is not required for breach of senescence for immortalization and transformation, the frequently deregulated mTOR signaling during multistep oncogenic processes could contribute to the development of the Warburg effect in many cancers. Components of the mTOR/HIF1α/Myc–hnRNPs/PKM2 glycolysis signaling network could be targeted for the treatment of cancer caused by an aberrant RTK/PI3K/AKT/mTOR signaling pathway.

ULK1-dependent phosphorylation of PKM2 antagonizes O-GlcNAcylation and regulates the Warburg effect in breast cancer

Nuclear PKM2 Regulates the Warburg Effect.

PKM2 Dephosphorylation by Cdc25A Promotes the Warburg Effect and Tumorigenesis

PKM2 Coordinates Glycolysis with Mitochondrial Fusion and Oxidative Phosphorylation

Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

PKM2 Promotes Glucose Metabolism Through a Let-7A-5p/stat3/hnrnp-a1 Regulatory Feedback Loop in Breast Cancer Cells

Acetylation Targets the M2 Isoform of Pyruvate Kinase for Degradation Through Chaperone-Mediated Autophagy and Promotes Tumor Growth.

O-GlcNAcylation Promotes Pancreatic Tumor Growth by Regulating Malate Dehydrogenase 1

Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth

O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth

Epigenetic Regulation of the Warburg Effect by H2B Monoubiquitination

PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis

PKM2 Promotes Reductive Glutamine Metabolism

PKM2 Regulates Chromosome Segregation and Mitosis Progression of Tumor Cells.

The Responsively Decreased PKM2 Facilitates the Survival of Pancreatic Cancer Cells in Hypoglucose

Pyruvate Kinase M2 Coordinates Metabolism Switch Between Glycolysis and Glutaminolysis in Cancer Cells

Mitochondrial PKM2 Regulates Oxidative Stress-Induced Apoptosis by Stabilizing Bcl2

Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics

Proviral Insertion in Murine Lymphomas 2 (PIM2) Oncogene Phosphorylates Pyruvate Kinase M2 (PKM2) and Promotes Glycolysis in Cancer Cells

Aurora A–mediated pyruvate kinase M2 phosphorylation promotes biosynthesis with glycolytic metabolites and tumor cell cycle progression

PKM2 Is Essential for Bladder Cancer Growth and Maintenance